Occupation: Research House
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants.
Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries.
Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584).
Run by a team of highly experienced professionals, our aim is to provide the research of choice for companies, investment banks and institutional investors. We provide independent reports, forecasts and valuations on each company we cover. We help clients gain access to investors, and facilitate feedback from the investment community on companies, their management and strategies. Our research strives to be objective, insightful, financially rigorous, readable and timely.
Web Address: http://www.edisongroup.com
280 High Holborn
Tel: Tel: +44 (0)20 3077 5700
Avalon’s announcement that it has entered into a refining agreement with Belgian chemicals company Solvay can be seen as a major de-risking event. Of most importance is that this agreement provides a lower-risk development and financing path towards securing future revenues from Nechalacho via third-party toll treatment of its rare earth element (REE) bearing concentrates. It should also allow Avalon to more easily secure offtake…
StatPro’s FY13 results were in line with the January trading update and we are broadly maintaining our FY14 numbers. However, we anticipate growth will pick up in FY15, as the R+ platform is expected to launch in early 2015. As we said in January, the group’s transition to a pure cloud business is now advanced and we continue to see significant upside potential, as US…
Foreign & Colonial Investment Trust (FRCL) is the oldest UK investment trust and one of the largest and most liquid, with a market capitalisation of £2.2bn and a largely retail investor base. Manager Jeremy Tigue, who has run the trust since 1997, will retire at the end of 2014 and management will pass to Paul Niven from 1 July. The trust seeks growth in both…
Pan African's (PAF) H1 results to end-December were its first with Evander fully consolidated for the entire period. Despite a lower gold price, frequent power interruptions and the febrile environment in the South African mining industry generally, PAF recorded an 11.8% increase in EPS in sterling terms compared to the previous year period. In total, the company produced 96,507oz of gold (193koz annualised) at a…
Bionomics will shortly see the outcome of its Phase II study of its lead drug, the vascular disrupting agent (VDA) BNC105, in second-line renal cell carcinoma. In our view, this represents a major stock price catalyst. Bionomics has recently reported an encouraging response rate in the first stage of its separate Phase I/II trial of BNC105 in recurrent ovarian cancer. We have updated our current…